Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950103-26-006962
Filing Date
2026-05-07
Accepted
2026-05-07 16:56:54
Documents
15
Effectiveness Date
2026-05-07

Document Format Files

Seq Description Document Type Size
1 FORM S-8 dp246328_s8.htm S-8 45127
2 EXHIBIT 5.1 dp246328_ex0501.htm EX-5.1 6387
3 EXHIBIT 23.1 dp246328_ex2301.htm EX-23.1 2425
4 EXHIBIT 99.1 dp246328_ex9901.htm EX-99.1 150482
5 EX-FILING FEES dp246328_exfilingfees.htm   iXBRL EX-FILING FEES 13236
6 GRAPHIC image_001.jpg GRAPHIC 1537
  Complete submission text file 0000950103-26-006962.txt   341401

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT dp246328_exfilingfees_htm.xml XML 5167
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

EIN.: 061397316 | Fiscal Year End: 1227
Type: S-8 | Act: 33 | File No.: 333-295649 | Film No.: 26954597
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)